Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Submaximal Exercise Gas Exchange is an Important Prognostic Tool to Predict Adverse Outcomes in Heart Failure
Woods, Paul R., Bailey, Kent R. , Wood, Christina M., Johnson, Bruce D.

Mayo Clinic

European Journal of Heart Failure | October 29, 2010 | Volume: 13 | Issue: 3 | Pages: 303-310

10.1093/eurjhf/hfq187 | PMID 21036777 Get It

Abstract Aims Traditionally, VO2peak has been used to determine prognosis in heart failure; however, this measure has limitations. Hence, other exercise and gas exchange parameters measured submaximally, e.g. breathing efficiency (VE/VCO2), end-tidal CO2 (PETCO2), oxygen uptake efficiency slope (OUES), and circulatory power [ systolic blood pressure (SBP)], have been investigated. The aim of this study was to investigate the prognostic relevance of submaximal exercise gas exchange in heart failure patients. Method and results One hundred and thirty-two consecutive heart failure patients (mean age 56 ± 12 years, ejection fraction 29 ± 11%) performed peak treadmill testing. Gas exchange and haemodynamic variables were measured continuously. Gas exchange data obtained from the first 2 min of exercise and at a respiratory exchange ratio (RER) of 0.9 were the measurements of interest. Over a median follow-up period of 62.4 (range 0–114) months, there were 44 endpoints (death or transplant). Univariate analysis demonstrated submaximal predictors of survival, which included VE/VCO2 slope and ratio, PETCO2, OUES, and circulatory power (P≤ 0.01). When these and additional submaximal variables were included together in the multivariable analysis, the strongest submaximal exercise predictive model (C-statistic 0.75) comprised data from the first stage of exercise (VE and circulatory power) and at an RER of 0.9 (VE/VCO2 ratio). The inclusion of VO2peak and demographic data, with submaximal data (VE/VCO2 ratio at an RER = 0.9), increased the predictiveness of the model (C-statistic 0.78). Conclusion Submaximal exercise measures provide useful prognostic information for predicting survival in heart failure. This form of testing is logistically easier, cheaper, and safer for patients compared with maximal exercise.
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Feldman, Andrew L. , Smith, David I., Ansell, Stephen M. , Johnson, Sarah H. , Porcher, Julie C., Özsan, Nazan , Wieben, Eric D. , Eckloff, Bruce W., Vasmatzis, George , Doǧan, Ahmet , Smith, David I., Law, Mark E. , Feldman, Andrew L

Mayo Clinic

Blood | October 29, 2010 | Volume: 117 | Issue: 3 | Pages: 915-919

10.1182/blood-2010-08-303305 | PMID 21030553 Get It

Abstract The genetics of peripheral T-cell lymphomas are poorly understood. The most well-characterized abnormalities are translocations involving ALK, occurring in approximately half of anaplastic large cell lymphomas (ALCLs). To gain insight into the genetics of ALCLs lacking ALK translocations, we combined mate-pair DNA library construction, massively parallel (“Next Generation”) sequencing, and a novel bioinformatic algorithm. We identified a balanced translocation disrupting the DUSP22 phosphatase gene on 6p25.3 and adjoining the FRA7H fragile site on 7q32.3 in a systemic ALK-negative ALCL. Using fluorescence in situ hybridization, we demonstrated that the t(6;7)(p25.3;q32.3) was recurrent in ALK-negative ALCLs. Furthermore, t(6;7)(p25.3;q32.3) was associated with down-regulation of DUSP22 and up-regulation of MIR29 microRNAs on 7q32.3. These findings represent the first recurrent translocation reported in ALK-negative ALCL and highlight the utility of massively parallel genomic sequencing to discover novel translocations in lymphoma and other cancers.
Influence of Cardiomegaly on Disordered Breathing During Exercise in Chronic Heart Failure
Olson, Thomas P. , Johnson, Bruce D.

Mayo Clinic

European Journal of Heart Failure | October 18, 2010 | Volume: 13 | Issue: 3 | Pages: 311-318

10.1093/eurjhf/hfq177 | PMID 20952768 Get It

Abstract Aims Heart failure (HF) patients breathe with a rapid shallow pattern during exercise. This study examined the relationship between cardiac size and tachypnoeic breathing in HF patients during exercise. Methods and results Thirty-seven HF patients [age = 55 ± 13 years, ejection fraction (EF) = 27 ± 10%, New York Heart Association (NYHA) class = 2.3 ± 1.2] and 42 controls (CTL) (age = 56 ± 14 years, EF = 63 ± 8%) were recruited. Participants underwent maximal exercise testing, pulmonary function testing, and chest radiography for calculation of total thoracic cavity volume (TTCV), diaphragm, heart, and lung volumes. Heart failure patients were divided into two groups: Group A = cardiac volume < median (n = 18) and Group B = cardiac volume ≥ median of the HF patients (n = 19). There was no difference between groups for TTCV (CTL = 8203 ± 1489 vs. Group A = 8694 ± 1249 vs. Group B = 8195 ± 1823 cm3). Cardiac volume was different between groups for both absolute (CTL = 630 ± 181 vs. Group A = 894 ± 186 vs. Group B = 1401 ± 382 cm3, P< 0.001 for all comparisons) and %TTCV (CTL = 8 ± 2 vs. Group A = 10 ± 1 vs. Group A = 18 ± 5%, P< 0.001 for all comparisons). Similarly, total lung volume as a %TTCV was significantly different among the groups (CTL = 70 ± 4 vs. Group A = 65 ± 5 vs. Group A = 58 ± 7%, P< 0.01 for all comparisons). In HF patients, there was a trend (P = 0.10) towards an independent association between cardiac size and tidal volume (VT) at 75% of VO2 peak whereas this relationship was statistically significant at VO2 peak (P = 0.02) as patients with larger cardiac size had reduced VT. Conclusion This study demonstrates the close relationship between cardiac size and breathing pattern during exercise in HF patients. These results suggest cardiac size may pose a significant constraint on the lungs during exercise and may contribute to tachypnoeic breathing.
Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial”
Packer, Douglas L. , Frantz, Robert P. , Prutkin, Jordan M. , Poole, Jeanne E. , Hellkamp, Anne S., Wood, Freda, McNulty, Steve E., Rogers, Joseph G. , Mark, Daniel B. , Lee, Kerry L. , Mitchell, L. Brent, Bernstein, Robert, Boehmer, John , Carlson, Mark D., Anderson, Jill, Bardy, Gust H., Johnson, George, Walsh, Mary Norine , Frantz, Robert P , Mark, Daniel B

Mayo Clinic

Circulation | October 11, 2010 | Volume: 122 | Issue: 15 | Pages: No page available

10.1161/circulationaha.110.951806 Get It

Accuracy in the Use of Traditional Cun Measurement Techniques for Localizing Classical Acupoints in the Upper Extremity: An Experimental Study
Dorsher, Peter T. , Johnson, AL

Mayo Clinic

Medical Acupuncture | September 13, 2010 | Volume: 22 | Issue: 3 | Pages: 191-195

10.1089/acu.2010.0759 Get It

Abstract Background: The locations of most of the 361 classical acupuncture points are determined in clinical practice by measuring their traditionally described positions using the cun system. Some data suggest the routinely taught methods of cun measurement may lead to inaccurate acupoint localizations. Objectives: To determine the accuracy of the traditional cun measuring techniques in localizing acupoints LU 4 and TE 8 compared with tape measure determination of their optimal locations, and to assess if the ability to accurately localize these points correlates with the length of acupuncture experience. Design, Setting, and Participants: Nonrandomized, experimental study conducted with 20 physician-acupuncturists on 2 adult volunteers at a medical acupuncture conference in Fall 2009. Eleven acupuncturists independently marked the location of LU 4, and 9 acupuncturists marked the location of TE 8 by traditional cun measuring techniques on the 2 volunteers, utilizing a novel point-marking method that blinded each acupuncturist from the others' point location findings. The optimal locations for the 2 acupoints were determined by direct measurement using a tape measure. Main Outcome Measures: Distances in millimeters of the clinicians' acupuncture point localizations from the optimal point positions. Results: For LU 4, the mean inaccuracy in locating this point using traditional measurement methods was 22.3 mm (range, 5-44 mm; SD = 10.9 mm). For TE 8, the mean inaccuracy was 8.4 mm (range, 1-21 mm; SD = 5.4 mm). Years of acupuncture experience (≤10 vs >10) did not affect the accuracy of clinicians' point localizations. Conclusions: Traditional cun methods routinely used to locate acupuncture points can produce enough inaccuracy in point localization that incorrect nearby acupoints could be needled inadvertently, irrespective of the amount of clinical experience of the acupuncturist. False-negative acupuncture intervention results (i.e., no beneficial clinical effect) in clinical trials could result.
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Moraska, Amanda R., Sood, Amit , Dakhil, Shaker R. , Sloan, Jeff A. , Barton, Debra L. , Atherton, Pamela J., Suh, Jason , Griffin, Patricia, Johnson, David , Ali, Aneela, Silberstein, Peter T., Duane, Steven F., Loprinzi, Charles L. , Atherton, Philip J. , Atherton, Pamela J., Atherton, Philip J.

Mayo Clinic

Journal of Clinical Oncology | July 13, 2010 | Volume: 28 | Issue: 23 | Pages: 3673-3679

10.1200/jco.2010.28.1444 | PMID 20625123 Get It

PurposeFatigue is one of the most common symptoms experienced by patients with cancer. This trial was developed to evaluate the efficacy of long-acting methylphenidate for improving cancer-related fatigue and to assess its toxicities.Patients and MethodsAdults with cancer were randomly assigned in a double-blinded manner to receive methylphenidate (target dose, 54 mg/d) or placebo for 4 weeks. The Brief Fatigue Inventory was the primary outcome measure, while secondary outcome measures included a Symptom Experience Diary (SED), the Short Form-36 (SF-36) Vitality Subscale, a linear analog self-assessment, the Pittsburgh Sleep Quality Index, and the Subject Global Impression of Change.ResultsIn total, 148 patients were enrolled. Using an area under the serum concentration-time curve analysis, there was no evidence that methylphenidate, as compared with placebo, improved the primary end point of cancer-related fatigue in this patient population (P = .35). Comparisons of secondary end points, including clinically significant changes in quality-of-life variables and cancer-related fatigue change from baseline, were similarly negative. However, a subset analysis suggested that patients with more severe fatigue and/or with more advanced disease did have some fatigue improvement with methylphenidate (eg, in patients with stage III or IV disease, the mean improvement in usual fatigue was 19.7 with methylphenidate v 2.1 with placebo; P = .02). There was a significant difference in self-reported toxicities (SED), with increased levels of nervousness and appetite loss in the methylphenidate arm.ConclusionThis clinical trial was unable to support the primary prestudy hypothesis that the chosen long-acting methylphenidate product would decrease cancer-related fatigue.
P3‐425: Chaperone‐mediated modulation of tau aggregation correlates with modifications in tau pathology and synaptic plasticity
Kraft, Clara, Rogers, Justin, Jinwal, Umesh K., Johnson, Amelia G., Jansen‐West, Karen , Banko, Jessica L., Golde, Todd E. , Weeber, Edwin J. , Dickey, Chad A. , Abisambra, Jose F. , Blair, Laura J. , Jones, Jeffrey R. , Hill, Shannon E. , Koren, John , Lawson, Lisa Y. , Muschol, Martin

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_19 | Pages: No page available

10.1016/j.jalz.2010.05.1968 Get It

Reducing the Radiation Dose for CT Colonography Using Adaptive Statistical Iterative Reconstruction: A Pilot Study
Flicek, Kristina T. , Hara, Amy K., Silva, Alvin C. , Peter, Mary Beth, Johnson, C. Daniel, Wu, Qing Feng

Mayo Clinic

American Journal of Roentgenology | June 21, 2010 | Volume: 195 | Issue: 1 | Pages: 126-131

10.2214/ajr.09.3855 | PMID 20566805 Get It

Can Radiologist Training and Testing Ensure High Performance in CT Colonography? Lessons From the National CT Colonography Trial
Chen, Mei‐Hsiu , Herman, B. , Johnson, C. Daniel, Toledano, Alicia Y. , Dachman, Abraham H. , Hara, Amy K., Fidler, Jeff L. , Menias, Christine O. , Kuo, Mark , Horton, Karen M., Cheema, Jugesh I., Iyer, R. Rajagopalan , Siewert, Bettina , Obregon, Richard G., Zimmerman, Peter, Halvorsen, Robert A., Casola, Giovanna, Morrin, Martina, Fletcher, Joel G. , Fidler, Jeff L. , Coakley, Kevin J. , Yee, Judy

Mayo Clinic

American Journal of Roentgenology | June 21, 2010 | Volume: 195 | Issue: 1 | Pages: 117-125

10.2214/ajr.09.3659 | PMID 20566804 Get It

Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans
Schrage, William G. , Wilkins, Brad W. , Johnson, Christopher P., Eisenach, John H., Limberg, Jacqueline K. , Dietz, Niki M., Curry, Timothy B. , Joyner, Michael J. , Joyner, Michael J

Mayo Clinic

Journal of Applied Physiology | June 18, 2010 | Volume: 109 | Issue: 3 | Pages: 768-777

10.1152/japplphysiol.00326.2010 | PMID 20558755 Get It

The vasodilator signals regulating muscle blood flow during exercise are unclear. We tested the hypothesis that in young adults leg muscle vasodilation during steady-state exercise would be reduced independently by sequential pharmacological inhibition of nitric oxide synthase (NOS) and cyclooxygenase (COX) with NG-nitro-l-arginine methyl ester (l-NAME) and ketorolac, respectively. We tested a second hypothesis that NOS and COX inhibition would increase leg oxygen consumption (V̇o2) based on the reported inhibition of mitochondrial respiration by nitric oxide. In 13 young adults, we measured heart rate (ECG), blood pressure (femoral venous and arterial catheters), blood gases, and venous oxygen saturation (indwelling femoral venous oximeter) during prolonged (25 min) steady-state dynamic knee extension exercise (60 kick/min, 19 W). Leg blood flow (LBF) was determined by Doppler ultrasound of the femoral artery. Whole body V̇o2 was measured, and leg V̇o2 was calculated from blood gases and LBF. Resting intra-arterial infusions of acetylcholine (ACh) and nitroprusside (NTP) tested inhibitor efficacy. Leg vascular conductance (LVC) to ACh was reduced up to 53 ± 4% by l-NAME + ketorolac infusion, and the LVC responses to NTP were unaltered. Exercise increased LVC from 4 ± 1 to 33.1 ± 2 ml·min−1·mmHg−1 and tended to decrease after l-NAME infusion (31 ± 2 ml·min−1·mmHg−1, P = 0.09). With subsequent administration of ketorolac LVC decreased to 29.6 ± 2 ml·min−1·mmHg−1 ( P = 0.02; n = 9). While exercise continued, LVC returned to control values (33 ± 2 ml·min−1·mmHg−1) within 3 min, suggesting involvement of additional vasodilator mechanisms. In four additional subjects, LVC tended to decrease with l-NAME infusion alone ( P = 0.08) but did not demonstrate the transient recovery. Whole body and leg V̇o2 increased with exercise but were not altered by l-NAME or l-NAME + ketorolac. These data indicate a modest role for NOS- and COX-mediated vasodilation in the leg of exercising humans during prolonged steady-state exercise, which can be restored acutely. Furthermore, NOS and COX do not appear to influence muscle V̇o2 in untrained healthy young adults.